Literature DB >> 3061932

Therapeutic strategies with monoclonal antibodies and immunoconjugates.

V S Byers1, R W Baldwin.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3061932      PMCID： PMC1385468     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  43 in total

1.  Do primary physicians actually manage their patients' fee-for-service care?

Authors:  A J Dietrich; E C Nelson; J W Kirk; M Zubkoff; G T O'Connor
Journal:  JAMA       Date:  1988-06-03       Impact factor: 56.272

Review 2.  Monoclonal antibodies and immunoconjugates for cancer treatment.

Authors:  R W Baldwin; V S Byers
Journal:  Cancer Chemother Biol Response Modif       Date:  1987

Review 3.  Anti-idiotypic antibodies and the induction of specific tumor immunity.

Authors:  G T Nepom; K E Hellström
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.

Authors:  V S Byers; I Pawluczyk; I Pawlucyzk; N Berry; L Durrant; R A Robins; M C Garnett; M R Price; R W Baldwin
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

5.  Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.

Authors:  M B Khazaeli; M N Saleh; R H Wheeler; W J Huster; H Holden; R Carrano; A F LoBuglio
Journal:  J Natl Cancer Inst       Date:  1988-08-17       Impact factor: 13.506

6.  Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.

Authors:  O W Press; J A Hansen; A Farr; P J Martin
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

7.  A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.

Authors: 
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

8.  Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.

Authors:  R O Dillman; J C Beauregard; R E Sobol; I Royston; R M Bartholomew; P S Hagan; S E Halpern
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

9.  Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.

Authors:  N Endo; Y Takeda; N Umemoto; K Kishida; K Watanabe; M Saito; Y Kato; T Hara
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

10.  The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M C Powell
Journal:  Nucl Med Commun       Date:  1988-04       Impact factor: 1.690
View more
  9 in total

1.  Design of protein struts for self-assembling nanoconstructs.

Authors:  Paul Hyman; Regina Valluzzi; Edward Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.

Authors:  A Mukhopadhyay; B Mukhopadhyay; R K Srivastava; S K Basu
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 4.  Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.

Authors:  E S Vitetta
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

5.  Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.

Authors:  R Obrist; J Schmidli; R Müller; H Gallati; J P Obrecht
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugates.

Authors:  V Singh; R Curtiss
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

Review 7.  Monoclonal antibodies in imaging and therapy of colorectal cancer.

Authors:  M K Lange; E W Martin
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

Review 8.  Antibody-directed targeting of the vasculature of solid tumors.

Authors:  P E Thorpe; F J Burrows
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

9.  Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.

Authors:  G B Sivolapenko; C Moreno; W Smith; J Corválan; M A Ritter; A A Epenetos
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.